Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 88,781

Document Document Title
WO/2015/200501A9
A high throughput method for identifying organisms which produce agents or classes of compounds. The method allows for the prioritizing or identifying those organisms having the most optimal success in producing the compound.  
WO/2015/196430A1
The expression plasmid vectors comprise a polynucleotide sequence encoding Ldc2 polypeptide, a fragment, and/or a mutant. A backbone plasmid is capable of autonomous replication in a host cell. The host cell is not a P. aeruginosa cell. ...  
WO/2015/196275A1
Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabichromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. ...  
WO/2015/199243A1
Provided are a novel hemagglutinin with which it is possible to remove cells rising above the undifferentiated state as occurs in colonies during culture of pluripotent stem cells, and a novel method for culturing pluripotent stem cells ...  
WO/2015/200519A2
The present invention describes applications and methods (1) to use bacterophage Cf and its variants to prevent and treat the citrus canker pathogen, Xanthomonas citri subsp. citri; (2) to engineer recombinant Cf phages that the infectiv...  
WO/2015/199441A1
The present invention relates to a translational fusion partner for secretory production of a target protein derived from the Pichia pastoris strain, a polynucleotide encoding the translational fusion partner, a recombinant expression ve...  
WO/2015/198193A1
A bioreactor vessel for culturing cells in a liquid environment is provided, the bioreactor vessel comprising: a tank, the tank including a side wall, a lid, and a bottom; sensors for reporting culture conditions; a sparger; a sprayer; a...  
WO/2015/199406A1
The present invention relates to an Escherichia sp. microorganism having L-tryptophan production capacity and, more specifically, to an Escherichia sp. microorganism having improved L-tryptophan production capacity by weakening or deacti...  
WO/2015/199349A1
The present invention relates to: an Aureobasidium pullulans KSY-0516 mutant strain producing extracellular secretion type β-1,3/1,6-glucan; a composition for enhancing immune activation and a health functional food containing the mutan...  
WO/2015/194628A1
 A method for manufacturing a lipid, the method comprising culturing a transgenic organism obtained by introducing a gene coding for any one protein selected from (A) through (C) into a host, and causing the transgenic organism to prod...  
WO/2015/195802A1
A method for amplifying and detecting microorganisms, such as species of Listeria, is described. The method utilizes gene-matched enrichment media and PCR-based detection. The enrichment media is spent media produced using a modified mic...  
WO/2015/193688A1
The invention is in the field of growth of Mycobacteria. In particular, agents have been identified which enhance the growth of Mycobacterial species, which are naturally slow-growing. Such agents can therefore be used in the identificat...  
WO/2015/193548A1
The present invention relates to microorganism biomass and a feed or food composition comprising said biomass for use in preventing or reducing the adverse effects of pathogens in animal or human digestive tract.  
WO/2015/193549A1
The present invention relates to hydrothermally processed microorganism biomassand a feed or food composition comprising said biomass for use in preventing or reducing the adverse effects of mycotoxinsin animal or human digestive tract.  
WO/2015/192172A1
The present invention relates to methods for enhancing at least one growth parameter of a leguminous plant via co-inoculation of a leguminous plant with at least one rhizobial microorganism together with at least one actinobacterial micr...  
WO/2015/195845A1
Microbes can be genetically modified to express biomolecules that are beneficial to mammals and/or to reduce, or eliminate, expression of harmful virulence factors. The growth and viability of such genetically modified microbes can optio...  
WO/2015/194921A1
The present invention relates to: a novel Pichia kudriavzevii strain NG7 showing heat resistance and acid resistance; a composition, for producing organic acid or alcohol, which comprises the strain and a cultured product of same; and a ...  
WO/2015/192383A1
A recombinant FeFe-nitrogenase system is identified with minimal genes active for nitrogen fixation in E.coli.  
WO/2015/194900A1
The present invention, with respect to Kluyveromyces marxianus, relates to a Kluyveromyces marxianus mutant strain of which an oxidized D-lactate dehydrogenase is inactivated, and to a method for producing lactic acid by means of the str...  
WO/2015/193348A1
The present invention concerns a recombinant yeast comprising a set of exogenous nucleic acids, with each nucleic acid encoding a polypeptide involved in the biosynthesis pathway of a vanilloid, said set of exogenous nucleic acids encodi...  
WO/2015/195703A1
This document describes biochemical pathways for producing glutaric acid, 5 aminopentanoic acid, 5-hydroxypentanoic acid or 1,5-pentanediol by forming one or two terminal functional groups, comprised of carboxyl, amine or hydroxyl group,...  
WO/2015/193449A1
The present invention provides methods of producing a fermented milk product comprising a step wherein milk is fermented in the presence of lactic acid bacteria and in the presence of lactase, wherein the lactic acid bacteria comprise ba...  
WO/2015/188224A1
The present invention relates to improved methods for the recombinant production of von Willebrand factor (vWF) in a bioreactor by separating different multimeric forms of vWF with different molecular weight during fermentation.  
WO/2015/189328A1
The present invention relates to a novel fish pathogen, in particular a novel Tenacibaculum specie involved in the development of tenacibaculosis in farmed fish. More particularly, the present invention relates to a vaccine useful in pro...  
WO/2015/192009A3
Disclosed are yeast expression constructs encoding a polypeptide containing a signal sequence, a Gol gi -di recti ng pro sequence, and a human amyloid beta protein, and mammalian expression constructs encoding a polypeptide containing a ...  
WO/2015/189352A1
The present invention relates to oleaginous yeast strains overexpressing a hexokinase gene, wherein said strains are capable of accumulating lipids. Methods for obtaining said strains as well as methods for producing lipids are also disc...  
WO/2015/190632A1
The present invention relates to recombinant microorganisms having terephthalic acid productivity and a terephthalic acid preparation method using same and particularly to: a recombinant microorganism for terephthalic acid production fro...  
WO/2015/191744A1
Provided are methods and compositions for inhibiting or reducing fungal growth in or on a subject. The methods comprise exposing the subject to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extra...  
WO/2015/190083A1
 A calcium reporter protein that exhibits superior fluorescence properties and calcium reactivity is obtained by providing DNA in which one nucleotide among the nucleotide coding the calmodulin-binding sequence (ckkap sequence) of the ...  
WO/2015/190627A1
The present invention relates to a method for minutely regulating gene expression using a synthesis-regulating sRNA in a prokaryotic cell and, more specifically, to a synthesis-regulating sRNA capable of minutely regulating the expressio...  
WO/2015/190458A1
The present invention provides a method for producing a recombinant protein by bacteria of the genus Brevibacillus that can be scaled up to an industrial scale and makes it possible to improve the levels of secretion and production of re...  
WO/2015/191611A1
The present disclosure provides recombinant bacteria with elevated production of ethanol and/or n-butanol from ethylene. Methods for the production of the recombinant bacteria, as well as for use thereof for production of ethanol and/or ...  
WO/2015/191422A1
Omega-hydroxylated carboxylic acids are made using a reverse beta oxidation cycle either by beginning with omega-functionalized CoA thioester primers or by omega functionalization of β-oxidation intermediate(s)/product(s). Bacteria and ...  
WO/2015/190116A1
In this microalgae culture method for culturing microalgae using a culture medium, the ratio of the molar concentration of phosphorus to the molar concentration of nitrogen in the culture medium when culturing starts is within the range ...  
WO/2015/191972A3
Omega functionalized chemicals are made using a reverse beta oxidation cycle either by beginning with particular primers or by omega functionalization of β-oxidation intermediate(s)/product(s). Bacteria and methods for same are provided.  
WO/2015/186721A1
 In order to provide an antibody or antibody fragment including the variable region of said antibody for the H5 subtypes of the avian influenza virus, an antigen polypeptide, and uses thereof, the present invention provides: an antibod...  
WO/2015/186990A1
The present invention relates to a microorganism for producing o-acetyl-homoserine with high efficiency and a method for producing o-acetyl-homoserine and L-methionine using same. Disclosed are a microorganism for producing o-acetyl-homo...  
WO/2015/186298A1
 Provided is a novel improved nitrile hydratase with improved resistance to amide compounds under high temperatures. Specifically provided is a nitrile hydratase having at least one amino acid mutation selected from (a) to (d) below, i...  
WO/2015/186958A1
Provided are a microorganism having an ability to produce O-succinylhomoserine or succinic acid and a method for producing O-succinylhomoserine or succinic acid by using the same.  
WO/2015/185669A1
Recombinant strains of Mycobacterium bovis bacille Calmette-Guerin (M. bovis BCG) comprising a heterologous nucleic acid sequence of Mycobacterium marinum (M. marinum) are provided. In some embodiments the heterologous nucleic acid seque...  
WO/2015/184941A1
Provided is a nanometer antibody for human CD7 molecule and an encoding DNA sequence thereof. The nanometer antibody can be efficiently expressed in Escherichia coli, and can be used for preparing an agent for the detection of CD7 molecu...  
WO/2015/185535A1
Process for continuous inoculation of a food product, in particular a dairy product, with ferments, comprising the following steps : - so lid concentrated ferments are transformed into liquid concentrated ferments, - the transformed conc...  
WO/2015/184935A1
Provided is a bacillus tequilensis ZSGD5, which is preserved on January 6, 2014 with an accession number being CCTCC NO: M 2014004. Also provided is a composite micro-ecological bacillus preparation, which is composed of the following st...  
WO/2015/187378A1
The invention provides a method for purifying a biomass hydrolysate comprising sugars and suspended particles, comprising centrifuging the biomass hydrolysate, thermally treating the centrifuged hydrolysate to chemically or physically ag...  
WO/2015/187779A1
Antibodies having Fab regions that specifically bind to Staphylococcus aureus protein A are capable of mediating opsinization of Staphylococcus aureus bacteria despite their expression of antibody-neutralizing protein A. These antibodies...  
WO/2015/182140A1
 Provided is a culture medium for anchorage-dependent cells as a technology that enables anchorage-dependent cells to be cultured without using a substratum, said medium containing milk fat globule-EGF factor 8 (MFG-E8) or protein frag...  
WO/2015/183052A1
The present invention relates to a method for quantifying and detecting aminocaproic acid by using a redesigned gene circuit. Since the redesigned gene circuit recognizing aminocaproic acid according to the present invention induces the ...  
WO/2015/182735A1
 The purpose of the present invention is to provide a composition for enhancing the immunopotentiating effect of lactic acid bacteria to enhance the immunopotentiating effect of lactic acid bacteria having an immunopotentiating effect,...  
WO/2015/182941A1
The present invention relates to a novel signal sequence for mass-expression of catalase and a use thereof and, more specifically, to a novel lipase signal sequence; an expression vector comprising the signal sequence and a catalase gene...  
WO/2015/180362A1
Provided are a mesophile ethanol-tolerant beta-glucosidase and a coding gene and use thereof. The amino acid sequence of the mesophile ethanol-tolerant beta-glucosidase is shown as SEQ ID NO:2, and the nucleotide sequence of the coding g...  

Matches 251 - 300 out of 88,781